On June 9, the European Union Drugs Agency (EUDA) released its 2026 European Drug Report, covering the 27 member states plus Norway and Türkiye. The findings paint a stark picture: drugs are more accessible, more potent, and harder to intercept than ever before. Synthetic substances have grown stronger, supply chains have become more sophisticated, and trafficking-related violence has spiked near major ports such as Antwerp, Rotterdam, and Hamburg.
The EUDA estimates that at least 7,600 people died from overdoses in the EU in 2024, with polysubstance use—particularly involving opioids—as the primary cause. This marks a worrying trend that the bloc is now scrambling to address.
A New Strategy for a Changing Landscape
On June 4, the Council of the European Union approved a new Drugs Strategy that will run until 2030. The plan is built on five pillars: preparedness, public health, security, harm prevention, and international cooperation. It also includes a dedicated strategy for ports—critical chokepoints for drug flows—and grants expanded powers to Europol, Frontex, and the EUDA.
The strategy represents the EU's first comprehensive attempt to tackle both traditional trafficking and the rise of synthetic drugs. However, critics argue that the approach leans too heavily on policing and security measures at the expense of public health interventions. “We risk repeating the mistakes of the war on drugs,” said one public health expert who spoke on condition of anonymity. “Without robust harm reduction and treatment programs, we will only see more deaths.”
For a deeper look at the financial commitments behind this effort, see our coverage of the EU Unveils €31 Billion Drug Strategy to Combat Rising Deaths and Trafficking.
Synthetic Threats and Port Security
The report highlights that synthetic drugs—such as fentanyl analogues and new psychoactive substances—are increasingly replacing plant-based drugs like heroin and cocaine. These substances are easier to produce in clandestine labs and can be shipped in small, hard-to-detect packages. The EUDA warns that the bloc's ports are becoming key entry points, with criminal networks exploiting legitimate trade routes.
In response, the new strategy prioritizes intelligence-sharing and joint operations at ports. Europol will receive additional resources to coordinate cross-border investigations, while Frontex will bolster surveillance at external borders. The EUDA itself will expand its early warning system to detect new substances faster.
This focus on security has drawn mixed reactions. Some member states, particularly those with major ports like the Netherlands and Belgium, welcome the increased support. Others worry about the potential for over-policing and the erosion of civil liberties. The strategy also includes measures to work with source and transit countries outside the EU, aiming to disrupt supply chains at their origin.
For context on how the EU is balancing security with other priorities, read our analysis of the EU Adopts First Comprehensive Drug Strategy to Combat Trafficking and Overdose Crisis.
Public Health Under Pressure
Despite the emphasis on security, the strategy does acknowledge the need for public health measures. It calls for expanded access to naloxone—a life-saving opioid overdose reversal drug—and for better treatment options for addiction. However, funding for these programs remains unclear, and critics say the rhetoric does not match the reality.
The EUDA report notes that only a fraction of people with drug use disorders receive treatment, and that stigma continues to be a major barrier. “We need to treat addiction as a health issue, not a criminal one,” said a spokesperson for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), which was recently rebranded as the EUDA. The agency argues that harm reduction services, such as supervised consumption rooms and needle exchange programs, have proven effective but remain underutilized in many member states.
The strategy also includes a focus on prevention, particularly among young people. Educational campaigns and early intervention programs are planned, but their implementation will depend on national governments.
International Cooperation and Future Challenges
The EU's strategy extends beyond its borders, aiming to strengthen cooperation with countries in the Balkans, Latin America, and West Africa—key regions for drug production and transit. The bloc will also work with international organizations like the United Nations Office on Drugs and Crime (UNODC) to share intelligence and best practices.
One of the biggest challenges ahead is the rapid evolution of synthetic drugs. As soon as one substance is banned, chemists tweak its molecular structure to create a new, legal variant. The EUDA's early warning system will need to keep pace, but experts warn that regulatory lag is inevitable.
For a broader view of how the EU is managing complex security threats, see our piece on EU's De-Risking Strategy: Can Europe Reduce Its China Dependency Without Decoupling?.
The new strategy is ambitious, but its success will depend on implementation. With overdose deaths rising and synthetic drugs becoming more dangerous, the EU faces a critical test of its ability to balance security and public health. The next few years will reveal whether this approach can stem the tide—or whether it will simply shift the problem elsewhere.
